NEW YORK (GenomeWeb News) – Caprotec Bioanalytics said this week that it has opened its US subsidiary, Caprotec, which is based in Burlington, Mass. The new subsidiary will be responsible for North American sales, marketing, and support for the Capture Compound Mass Spectrometry technology and related products.

The firm hired Christian Jurinke to serve as president of the US subsidiary, and it has inked a sales and marketing collaboration in North America with Genovative Solutions, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.